These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26636109)

  • 1. Maternal serum ischemia modified albumin as a marker for hypertensive disorders of pregnancy: a pilot study.
    Vyakaranam S; Bhongir AV; Patlolla D; Chintapally R
    Int J Reprod Contracept Obstet Gynecol; 2015 Jun; 4(3):611-616. PubMed ID: 26636109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal serum and fetal cord-blood ischemia-modified albumin concentrations in normal pregnancy and preeclampsia: a systematic review and meta-analysis.
    Seshadri Reddy V; Duggina P; Vedhantam M; Manne M; Varma N; Nagaram S
    J Matern Fetal Neonatal Med; 2018 Dec; 31(24):3255-3266. PubMed ID: 28817994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal serum ischemia-modified albumin: a biomarker to distinguish between normal pregnancy and preeclampsia?
    Gafsou B; Lefèvre G; Hennache B; Houfflin Debarge V; Ducloy-Bouthors AS
    Hypertens Pregnancy; 2010 Jan; 29(1):101-11. PubMed ID: 20132025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ischemia modified albumin in normal pregnancy and preeclampsia.
    van Rijn BB; Franx A; Sikkema JM; van Rijn HJ; Bruinse HW; Voorbij HA
    Hypertens Pregnancy; 2008; 27(2):159-67. PubMed ID: 18484421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal serum perlecan and ischemia modified albumin levels as biomarkers of preeclampsia severity.
    Mokhtar ER; Abd El-Hakam FA; Ebriheem EE; El Attar S; Hassan MM; Al Anany MG
    Egypt J Immunol; 2022 Jul; 29(3):64-79. PubMed ID: 35758970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating Ischemia-Modified Albumin as an Early Biomarker for Hypertensive Disorders During Pregnancy: A Case-Control Study.
    John JE; Sakarde A; Misra SS; Mundle S; Jose J; Tripathi SC; Amle D
    Cureus; 2022 Oct; 14(10):e30867. PubMed ID: 36457615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Maternal Serum Ischemia Modified Albumin (IMA) with Placental Histopathological Changes and Fetomaternal Outcome: A Prospective Case Control Study in Normotensive and Pre-eclamptic Women.
    Jaiswar SP; Verma S; Agrawal M; Deo S; Goel M; Mahdi AA
    J Obstet Gynaecol India; 2022 Aug; 72(Suppl 1):166-173. PubMed ID: 35928062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of serum uric acid and creatinine in hypertensive disorders of pregnancy.
    Vyakaranam S; Bhongir AV; Patlolla D; Chintapally R
    Int J Med Sci Public Health; 2015; 4(10):1424-1428. PubMed ID: 27175365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ischemia-Modified Albumin (IMA): A Novel Marker for Preeclampsia Independent of Uterine Artery Notching Identified by Doppler Ultrasound.
    Doğan K; Guraslan H; Çankaya A; Dağdeviren H; Ekin M
    Hypertens Pregnancy; 2015 Nov; 34(4):516-524. PubMed ID: 26636373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ischemia Modified Albumin as a Marker of Oxidative Stress in Normal Pregnancy.
    Bahinipati J; Mohapatra PC
    J Clin Diagn Res; 2016 Sep; 10(9):BC15-BC17. PubMed ID: 27790423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between oxidative stress and preeclampsia. The serum ischemia-modified albumin levels and thiol/disulfide homeostasis.
    Onat T; Aydoğan Kırmızı D; Başer E; Ercan M; Demir Çaltekin M; Yalçın S; Kara M; Esinler D; Yalvaç ES
    Turk J Obstet Gynecol; 2020 Jun; 17(2):102-107. PubMed ID: 32850184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IMA and IMAR in serum and saliva of preeclampsia--a preliminary study.
    D'souza JM; Pai VR; Harish S; Shriyan C; D'souza N
    Hypertens Pregnancy; 2014 Nov; 33(4):440-8. PubMed ID: 25019475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of maternal serum ischemia modified albumin and total antioxidant status in ectopic pregnancy.
    Bozkaya G; Karaca I; Fenercioglu O; Yildirim Karaca S; Bilgili S; Uzuncan N
    J Matern Fetal Neonatal Med; 2019 Jun; 32(12):2003-2008. PubMed ID: 29284337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First trimester maternal serum ischaemia-modified albumin: a marker of hypoxia-ischaemia-driven early trophoblast development.
    Prefumo F; Gaze DC; Papageorghiou AT; Collinson PO; Thilaganathan B
    Hum Reprod; 2007 Jul; 22(7):2029-32. PubMed ID: 17437959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A diagnostic test accuracy meta-analysis of maternal serum ischemia-modified albumin for detection of preeclampsia.
    Seshadri Reddy V; Munikumar M; Duggina P; Varma N
    J Matern Fetal Neonatal Med; 2019 Jul; 32(13):2173-2181. PubMed ID: 29325458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ischemia-modified albumin as an oxidative stress biomarker in early pregnancy loss.
    Cengiz H; Dagdeviren H; Kanawati A; Suzen Çaypinar S; Yesil A; Ekin M; Yasar L
    J Matern Fetal Neonatal Med; 2016; 29(11):1754-7. PubMed ID: 26135770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The novel ischemia marker 'ischemia-modified albumin' is increased in normal pregnancies.
    Guven S; Alver A; Mentese A; Ilhan FC; Calapoglu M; Unsal MA
    Acta Obstet Gynecol Scand; 2009; 88(4):479-82. PubMed ID: 19235558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ischemia-modified albumin in preterm infants born to mothers with pre-eclampsia.
    Özdemir ÖM; Özdemir E; Enli Y; Öztekin Ö; Ergin H
    Pediatr Int; 2018 Jun; 60(6):553-559. PubMed ID: 29570915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Ischemia-modified Albumin as a Biomarker in Preeclampsia.
    Karaşin SS; Çift T
    Rev Bras Ginecol Obstet; 2020 Mar; 42(3):133-139. PubMed ID: 32232820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of ischemia-modified albumin in the evaluation of oxidative stress in intrahepatic cholestasis of pregnancy.
    Tayyar AT; Kozalı S; Yetkin Yildirim G; Karakus R; Yuksel IT; Erel O; Neselioglu S; Eroglu M
    J Matern Fetal Neonatal Med; 2019 Nov; 32(22):3836-3840. PubMed ID: 29739259
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.